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Coronavirus (CoV) outbreaks have recently emerged as a global public health threat due
to their exceptional zoonotic potential — a feature arising from their ability to infect a
diverse range of potential hosts combined with their high capacity for mutation and
recombination. After Severe Acute Respiratory Syndrome (SARS) CoV-1 in 2003 and
Middle East Respiratory Syndrome (MERS) CoV in 2012, with the current SARS-CoV-2
pandemic we are now in the midst of the third deadly international CoV outbreak in less
than 20 years. Coronavirus outbreaks present a critical threat to global public health and
an urgent necessity for therapeutic options. Here, we critically examine the current
evidence for ion channel activity in CoV proteins and the potential for modulation as a
therapeutic approach.
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INTRODUCTION
Coronaviruses (CoVs) are enveloped, single-stranded, positive-sense RNA viruses that were first
discovered in the 1930s (1). They are recognized as underlying frequent and deadly enzootic
outbreaks in livestock (2), but their propensity for cross-species transmission has led to repeated
human coronavirus (CoV) outbreaks, including the COVID-19 pandemic currently sweeping the
world. According to the European Centre for Disease Prevention and Control, as of August 2020,
Coronavirus disease 2019 (COVID−19) has caused >800,000 deaths and effective therapeutic
options remain limited. Months or years may pass before successful vaccine-development efforts
come to fruition, but alternative therapeutic efficacy may arise from “anti-viral” mechanisms that
reduce viral fitness by interfering with stages of the viral life cycle, such as viral entry, release,
assembly, and exit, or from “pro-host” mechanisms that improve host fitness by directly targeting
virulence factors, thereby disrupting the fundamental origins of tissue damage and pathology. In
reality, anti-viral and pro-host mechanisms may well overlap, since viral proteins often play
multiple discrete functional roles that drive both pro-viral and anti-host consequences. This
functional complexity points to a need for detailed understanding of underlying structure-
activity-function phenomena.
Coronaviruses are spherical particles with diameter of ~125 nm enclosed in an envelope bilayer,
in which the membrane (M), envelope (E) and spike (S) structural proteins are embedded (3). The S
protein generates the surface spikes that mediate receptor binding and membrane fusion between
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the virus and the host cell, while the E and M proteins maintain the
envelope shape (4). Inside the viral envelope, nucleocapsid (N)
proteins stabilize the single-stranded RNA genome (4). Many
studies have established the relevance of the E protein and
protein 3a as fundamental pro-inflammatory SARS-CoV
virulence factors (5–8), and additional studies have suggested that
the inflammatory properties of E and 3a are related to their
induction of ion conductances in membranes, i.e. that they are
ion channel proteins (9–12). Since the initial characterization of
influenza M2 (13), viral proteins which form ion channels
themselves (viroporins) (14), or which can modulate host cell ion
channel function (e.g. HIV-1 Vpu) (15, 16), have been reported in a
variety of virus species (17), and repeatedly proposed as potential
anti-viral drug targets (17–19). Some proposed viroporins are
proteins with structural features that are conserved in bacterial/
eukaryotic proteins, such as the viral K channel Kcv (14, 20), which
contains the canonical, highly conserved, potassium-selectivity filter
that is found throughout the prokaryota and eukaryota. Others
include a diverse range of short peptide/proteins, typically 50 to 120
amino acids, which are predicted or have been shown to contain at
least one transmembrane helix and may oligomerize to form
channel-like structures with hydrophilic pores, but otherwise
carry no primary structural clues to any channel nature. Ion
channels in general are attractive drug-targets which account for
~15% of clinically used drugs (21). In principle the lack of homology
between the proposed CoV viroporins and human ion channels
provides the potential for selective modulation with small molecule
or biologic therapies, and modern technologies allow for high-
throughput screening of novel channel modulators (21). If major
drug-discovery endeavors are to be prudent, however, convincing
evidence should exist for the ion channel function of CoV proteins
as well as the anti-viral effects of their functional modulation.
Although there is also a wealth of detailed functional analysis
of a few viroporins, such as influenza M2 and Kcv [as reviewed in
(17, 19, 22)], most putative viral channels have received relatively
little electrophysiological attention, which typically requires
expression of putative channels in heterologous systems or
reconstitution of purified or synthesized peptides into artificial
bilayers. Such approaches can be technically fickle, with
important considerations for the interpretation of results, and
unequivocal determination of pore-forming proteins generally
requires detailed combinations of both electrophysiological
analysis and structural manipulation to avoid the potential for
mis-identification as a consequence of reconstitution of
contaminant proteins or altered regulation of endogenous
channels in heterologous expression systems (21, 23–25).
With these issues in mind, our aim is to review the relevant
studies and provide a critical assessment of the current evidence for
ion channel activity of SARS-CoV E protein, protein 3a, and protein
8a, and suggest potential studies to clarify existing uncertainties.
E PROTEIN
The envelope protein E is a small (~8–12 kDa) integral
membrane protein, the biological significance of which has
been comprehensively reviewed elsewhere (2). It is highly
expressed in host cells during viral replication: a minor
fraction is incorporated into the virion envelope, while most
protein localizes in the endoplasmic reticulum, Golgi apparatus
or the ER-Golgi intermediate compartment (or ERGIC) of the
host cell, where CoVs bud (26, 27). E has variously been
implicated in virus assembly, budding, envelope formation,
virus release, inflammasome activation, and pathogenesis in
different CoVs (see (2) for review), and deletion of E in
recombinant viruses results in reduced viral propagation and
pathogenicity (2, 28, 29). E interacts with multiple viral- and
host-cell proteins and likely has multiple molecular functions (2),
either in addition to, or as a consequence of, its putative role as
an ion channel.
Evidence for Ion Channel Function of E
Early reports indicated that expression of the E protein from
SARS-CoV (30) and murine hepatitis virus (31), in E. coli or
mammalian cells, could increase membrane permeability to
multiple small molecules, although they did not establish
whether these molecules permeated channels formed directly
by E or whether expression of E increased membrane
permeability via an indirect mechanism (31).
Western blots indicate that the E protein normally
multimerizes, and a series of studies combining in silico and
biochemical methods and NMR spectroscopy (32) provided
evidence for pentameric assembly of E from SARS-CoV (33–
36) and MERS (37). The structural model includes a ~2Å radius
constriction, formed by the sidechains of V25 and V28, which
could conceivably act as a channel gate, and an extended central
“pore” of <6Å in radius (34) (Figure 1). The first
electrophysiological characterization of E reported fluctuating
currents, with indistinct gating events, and very poor signal-to-
noise, when synthetic SARS-CoV E, or E proteins from HCov-
229, mouse hepatitis virus (MHV) and from infectious bronchitis
virus (IBV) were reconstituted into artificial bilayers (38, 39).
Different apparent ion permeability series were observed: the a-
CoV HCoV-229 (K+ > Na+ > Cl−) differed from MHV (b-CoV)
and IBV (g-CoV) (both Na+ > K+ > Cl−) but, in all three,
selectivity inferences were based on reversal potential
measurements that were confounded by very small and
variable currents.
Guided by structural modeling, Torres, Liu, and colleagues
engineered mutations in a short-form of SARS-CoV E (limited to
the predicted transmembrane region, and flanked at both termini
by 2 lysine residues to aid with solubility), and reported that
N15A and V25F substitutions both altered oligomerization (2,
40), and abolished currents when proteins were reconstituted
into artificial bilayers (35). Here, we have to note that the
summary conductance values shown in their Figure 3 (35) are
not consistent with the example traces shown. In particular 2- to
3-fold higher conductance for F23A shown in their Figure 3 is
not evident in the traces provided. Curiously the double mutants
V25F/A32F and N15A/V25F restored conductances that were
qualitatively similar to those seen with the WT peptide. This,
coupled with the additional finding that WT-associated
conductances were abolished by amantadine, yet N15A/V25F-
associated conductances were not, led the authors to propose
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that the double mutant resulted in non-specific destabilization of
the membrane. That V25F/A32F currents were amantadine-
insensitive and reportedly displayed no ion selectivity, whereas
WT-associated conductances showed selectivity for calcium over
sodium (unfortunately no drug-sensitivity data was reported for
N15A/V25F double mutants), was consistent with this
interpretation. Incidentally, the relevant selectivity data [their
Figure 5 in (35)] was interpreted as demonstrating selectivity for
sodium over calcium but the methods state that membrane
voltage referred to the cis- relative to the 4 trans-bilayer
chamber, and CaCl2 was present in the trans- chamber, so the
(~20 mV) positive shift in the reversal potential would be
consistent with a preference for Ca2+ to Na+.
The calcium permeability of SARS-CoV E was further explored
by the same group, who reported that negatively-charged lipids
increased the permeability ratio for calcium over chloride (11). Lipid
composition also affected E-associated monovalent ion
conductances, with negatively charged lipids reducing apparent
unitary conductance in KCl and increasing monovalent-cation
selectivity over Cl−, compared with neutral membranes (44, 45).
A
B
FIGURE 1 | Proposed SARS-Cov E and 8a structures (A) Proposed homopentameric structure of the E protein (32), viewed (left) through the membrane, and (right)
on the plane of the membrane. The structural model includes a ~2Å radius constriction, formed by the sidechains of V25 and V28, which could conceivably act as a
channel gate, and an extended central “pore” of <6Å in radius (34) [From Surya et al. BBA-Biomembranes 2018 1860: 1309-1317. With publisher’s permission] (B).
Proposed pentameric structure of the 8a protein. (left) The single transmembrane domain (TMD) 8a 1–22 is shown at the beginning (0 ns) and end of a 50-ns MD
simulation, (right). Top view (left) and side view (right) of a pentameric bundle of 8a 1–22 at the beginning (upper) and end of 50 ns MD simulation (lower). The protein
backbones are drawn in blue with the side chains shown as sticks and van der Waals surface representation. Residues Thr-8, Ser-11, and 214 are shown in pink
and light red, respectively. All cysteine residues, Cys-9, 213, and 217, are shown in yellow. Phosphorous atoms of the lipids are shown in orange spheres. Lipid and
water molecules are omitted for clarity. [Relabeled from Hsu et al., Proteins. 2015; 83: 300–308. With publisher’s permission].
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Millimolar concentrations of calcium and changes in pH were
reported to alter K+:Cl− permeability ratios, suggestive of cation-
interactions with negative charges in a protein-lipid complex (11).
We have misgivings over the data presented in their Figure 1A,
which is claimed to show 2 channel events of identical amplitude,
but the example traces show the amplitudes to be obviously
different. Additionally, there was apparently no increase in
conductance when CaCl2 was increased symmetrically from ~5
mM to 300 mM (their Figure 1E), a result which seems
incompatible with a Ca2+-permeable conductance (44, 45).
The finding that E could mediate Ca2+ flux in lipid membranes
that mimic the high negative charge composition expected for ER
and Golgi intermediate compartment (ERGIC) membranes
prompted study of the potential for E to provoke abnormal
calcium handling and consequent NLRP3 inflammasome
activation in cells (11). Vero 6 cells transfected with cDNAs
encoding the inflammasome components NLRP3, ASC and
procaspase-1 and inactive pro-IL-1b secreted more active IL-1b
when E was expressed. Interestingly, this increase in IL-1b secretion
was attenuated when E loss-of-function mutants, N15A and V25F,
were expressed, or when Ca2+ was removed, but there was no
critical assessment of ion channel involvement, and effects of these
mutations on other E functions cannot be excluded.
Additional studies have focused on the effects of the N15A and
V25F mutations in SARS-CoV (10), or their equivalent mutations
(T16A, A26F) in IBV (46), in infected mice or Vero E6 cells.
SARS-CoV carrying the E protein N15A substitution caused
markedly reduced mortality in infected mice, and a partial
reversal in infection-related weight loss, whereas the
introduction of the V25F mutation had little effect on either
phenotype. Interestingly, it was found that mutant virus
propagation in both infected mice and cultured cells was
associated with the emergence of additional mutations. When
synthetic E transmembrane domain peptides carrying the
additional amino-acid substitutions were studied in bilayer
recordings, these “revertant” mutations restored transmembrane
conductances lost by the N15A or V25F substitutions. Higher
mortality associated with the V25F mutant (compared to N15A)
correlated with more rapid and extensive emergence of revertant
mutations in V25F-mutant strains (10). Similar results were
obtained in cells infected with T16A and A26F-mutant IBV (46).
In these studies, only very rudimentary electrophysiological
characterization of the revertant mutants was reported, i.e. the
appearance of trans-membrane currents, although certain
revertant mutations (such as the A26F/K58N double and
A26F/N11D/K58N triple mutants in IBV E protein) apparently
result in gross changes in channel behaviour (10). Such results
are broadly consistent with restoration of ion channel activity by
revertant mutations recovering pathogenicity although, if
channel behavior is indeed mechanistically associated with
pathogenicity, then mice or cells infected with functionally
very abnormal double/triple mutant channels might be
expected to show altered phenotypes.
E Ion Channel Pharmacology
Hexamethylene amiloride (HMA), an inhibitor of the HIV-1
Vpu virus ion channel, was reported to inhibit HCOV-229 and
MHV E, but not IBV E (which was, if anything, apparently
activated) (39). A single dose-response experiment returned an
IC50 <10 mM, consistent with potencies observed in plaque
formation assays showing HMA inhibition of virus plaque
growth for MHV. The authors argued that lack of HMA effect
on plaque growth in cells infected with MHV virus in which E
had been deleted (MHV DE) points toward an E-mediated effect
of HMA. However, from the examples shown, HMA-treated cells
infected with MHV DE appear to exhibit smaller plaques than
cells treated with amiloride, which was without effect on E
conductances, arguing against a causative effect of ion channel
conductance block (39). A useful further comparison would be to
determine the effect of HMA on IBV fitness, since IBV E was
reported to be insensitive to HMA and thus no effect of the drug
on IBV would be expected if the drug works via E viroporin
inhibition. In separate studies, amantadine was claimed to bind
to, and inhibit, SARS-CoV E based on surface plasmon
resonance and bilayer electrophysiology (35).
Potential Future Studies Into E Ion
Channel Function
Reports of very different ion channel properties for E proteins of
various different coronaviruses and, conversely, for the same protein
in different experiments, raises concerns that some results may be
artefactual. Of note, example bilayer recordings in some reports look
strikingly different from other reported E viroporin conductances,
with long-lived open states in both neutral and negatively charged
lipid bilayers (9, 11, 44, 45), contrasting with noisy, fluctuating
conductances previously reported (35, 38, 39). The reason for such
variable channel-gating behavior is not immediately apparent. Of
major concern, there is clear reproduction of the identical example
trace (with edited scale bars) being attributed to E in one publication
[Figure 3A (45)] and the SARS-CoV 3a protein in another [Figure
3A (9)]. Expression of SARS-CoV E in cellular membranes after
transient transfection of HEK293 cells (34) provides one potentially
useful approach for more detailed electrophysiological
characterization, and for confirmation of findings from
synthesized peptides in artificial bilayers. With consideration of
the published reports of lipid sensitivity (44, 45), properties intrinsic
to the protein would be expected to be conserved across different
experimental systems. One essential caveat to such an approach is of
course the possibility of modulation of endogenous proteins,
although acute inhibition of currents with anti-E antibodies, as
originally reported byWilson and colleagues (38, 39), could provide
evidence of at least close proximity and direct regulation.
Further experiments to determine ion selectivity could
involve substitution of both physiological cations and anions
with larger ions, and could be interpreted alongside the suggested
NMR structures to define the properties of the channel pore and
the relative contributions of ion radius and hydration on
permeation. Building on the reported differences in selectivity
for a-CoV (HCoV-229) vs b-CoV (MHV) and g-CoV (IBV), a
detailed selectivity series analysis combined with chimeric or
mutational approaches may help to determine which parts of the
proteins contribute to selectivity specifically, and how different E
proteins support distinct selectivity. Additional insights to E
channel function might be provided by studies of channel gating
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combined with mutagenesis, guided by, and iteratively refining,
structural models. Further, electrophysiological study could
dissect the mechanism of amantadine and HMA inhibition, by
including investigations of voltage-dependency of inhibition and
mutational scans of potential binding sites. Again, comparison of
HMA-sensitive E from HCOV-229 and MHV, versus HMA-
insensitive IBV, could reveal the basis for differential binding
and/or inhibition. Optimization of E expression in mammalian
cells could also facilitate high-throughput drug screening using
automated patch clamp or fluorescent indicators to screen for
both inhibitors or positive-modulators to generate experimental
therapeutics or key pharmacological tool compounds. Cross-
validation of any findings in cell lines by repetition in
reductionist bilayer experiments could confirm direct effects.
Extrapolating findings from heterologous systems to in vivo
function is complicated by the potential for function to vary
depending on the cellular localization of the protein, which must
always be considered.
3a Protein
The 3a protein [ORF3 (47), X1 (48), ORF3a (49) and U274 (50)]
is encoded by a gene located between the S and E genes within
the SNE (S neighbor E) locus in SARS-CoV genomes (48). The
majority of investigations into 3a function have focused on the
SARS-CoV protein. 3a from SARS-CoV-2, the virus responsible
for the COVID-19 pandemic, is more closely related to Bat
coronaviruses than SARS-CoV, although high sequence
similarity is maintained in critical regions (Figure 2) between
SARS-Cov and SARS-CoV-2. In particular, TM-helix polar
residues are well conserved, as is C133 which is critical for
oligomerization (see below), suggesting that the 3a proteins of
SARS-CoV-2 and SARS-CoV may have similar molecular
function and roles.
Heterologous expression in E. coli, as well as subsequent
immunohistochemistry of commercially prepared slides of
SARS‐CoV‐infected cells, revealed a bona fide protein product
in infected host cells (51). Subsequent studies have shown that 3a
predominantly localizes to the Golgi apparatus and plasma
membrane (51), as well as other subcellular organelles,
including endosomes and lysosomes, but rarely in ER or
mitochondria (49, 50). While first proposed to be non-
structural, later reports have suggested that 3a incorporates
into virus particles and directly interacts with the Spike (S),
Membrane (M) and E structural proteins and the accessory
protein orf7a (52–54). 3a has drawn major attention as a
potential SARS-CoV therapeutic target prompted by the
finding that 40-50% of convalescent SARS patients developed
antibodies against 3a N-terminal peptides (55–57). One study
reported that serum raised against the N-terminal peptide
showed a SARS-CoV neutralizing effect (58) although another
study showed no neutralizing effect by mouse serum immunized
by the 3a ectodomain peptide (55). Positive selection was
observed in 3a along with S during the SARS outbreak in 2003,
suggesting that the 3a protein may play a critical role in
adaptation to new environments and hence virus survival (59).
In the current COVID-19 pandemic, phylogenetic analysis has
identified three major lineages of SARS-CoV-2 throughout the
world, revealing a non-synonymous mutation (G26144T;
G251V) in the cytoplasmic domain of 3a that is more
prevalent in Europe and the US, and that distinguishes the
third group (60). No biological consequence of the mutation
has been established, but the fact that the G251 residue is
otherwise well conserved in SARS-CoV and SARS-CoV-2 may
reflect the importance of this residue and suggest that variation
may alter 3a function (Figure 2).
Roles of 3a in viral pathogenesis, virulence and disease
outcome have been extensively studied in both in vitro cell
cultures and in vivo in mice and Drosophila. Although the 3a
gene-deleted recombinant virus, SARS-CoV DORF3a, replicated
with slightly reduced efficiency in vitro and at a comparable level
to wild type viruses in mice (12, 61, 62), 3a expression in cultured
cells led to cytopathic effects (12, 63, 64) through both apoptotic
(62, 65, 66) and necrotic cell death pathways (12, 63), and
affected egress of virus from host cells. These results indicate
that 3a is not essential for virus particle formation but may affect
virus packaging and release. As an excellent in-depth review of 3a
can be found elsewhere (67), we limit our discussion to 3a
protein structure and its potential ion channel function.
3a Protein Structures
3a is a 31-kDa protein composed of an N-terminal ectodomain
(amino acids 1-39), three transmembrane helices (TM1, TM2,
TM3;40-128) and a cytoplasmic domain (129-274) (Figures 2,
3). Subunit association studies suggested that the proteins
assemble as homo-tetramers in a dimer-of-dimer configuration
(68), that is strictly dependent on the presence of C133 (68).
Kern et al. recently determined near-atomic resolution (2.8 Å)
single particle cryo-EM structures of the 3a protomer (dimer) as
well as a tetrameric (dimer-of-dimer) form (41). As expected
from the absence of sequence homology to any other proteins of
known structures, 3a protein adopted a novel fold with three
trans-membrane spanning helices, a cytoplasmic domain
consisting predominantly of two beta sheets, and a short alpha
helix connecting the two domains (Figure 3). Both
transmembrane and cytoplasmic domains from one subunit
form extensive interactions with the other subunit in the
protomer. Potential ion permeation pathways reside in each
dimer; hydrophobic bifurcated paths with a tight constriction
in the extracellular half (potentially consistent with the channel
being in a non-conductive state) are connected to a wide inner
cavity near the cytoplasmic end with two side openings to the
environment; one within a subunit between TM2 and TM3 with
hydrophobic residues lining the entrance and the other at the
subunit interface (TM1 and TM3) with polar and charged
residues lining the surface. An aspartic acid (D142) located at
the apex of the short alpha helix connecting the transmembrane
and cytoplasmic domain provides a single negatively charged
pore-lining residue between the inner cavity and the side
opening. These structural features suggest that the side
opening at the subunit interface may be the path for water and
ion movements. The low resolution (6.5 Å) electron density map
of tetramers reveals the side-by-side assembly of two protomers.
Interestingly C133, required for oligomeric assembly, is located
near the protomer interface without directly facing the interface,
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in close proximity to two other cysteines (C148 and C157),
potentially close enough to form disulfide bonds that may affect
oligomer stabilities (Figure 3).
3a Ion Channel Activity
3a was first claimed to be a K+ selective channel based on
experiments showing the presence of Ba2+-sensitive K+ currents
in transfected HEK293 cells (62), and in Xenopus oocytes injected
with 3a cRNA (68). Appropriate shifts of K+ reversal potentials
with asymmetric elevations in ion concentration corroborated K+
selectivity of the channel activity (18, 68–70). This correlation
between two different expression systems strengthens the
argument that 3a expression leads to appearance of a K+
conductance but, as noted above, such experiments cannot
trivially exclude the possibility that the 3a protein activates an
endogenous channel. For most ion channels, single-channel
conductances provide a molecular “signature” that is unique and
hence can define currents from endogenous or contaminant
channels in recombinant expression systems. Unfortunately,
while 3a expressed in oocyte membranes resulted in the
appearance of a mild outwardly-rectifying single channel
conductance, with a 90-pS slope conductance at positive
potentials (in 100 mM KCl), strikingly different and varying
properties were reported for 3a protein in bilayer experiments,
including currents with maximum conductance ~12 pS in
symmetrical 500 mM KCl) and maximum conductance ~56 pS
in symmetrical 500 mM CaCl2 (71). A ten-fold KCl gradient
(500:50 mM, cis:trans) in the same study resulted in a ~15 mV
shift in the reversal potential, indicative of a mild Cl− preference
(71). Anion-replacement or large cation-replacement experiments
would have been useful to rule out non-specific conductances
through bilayer perturbation and demonstrate whether there was
any true selectivity for different ion species. In sharp contrast,
another study purified 3a from High-Five insect cells and
performed single channel recordings in artificial bilayers,
claiming to show a mild selectivity for monovalent cations (9),
although, as noted, this was presented with a:representative trace”
that had been attributed as a SARS-CoV E channel current in a
previous publication (9, 45), seriously questioning the validity of
these studies. Kern et al. have now functionally characterized the
dimeric 3a proteins after reconstitution into synthetic liposomes
(41). They analyzed reversal potential shifts in bi-ionic conditions
to predict permeability ratios (PX/PK+): Ca
2+ ~2 > K+ ~1 > Na+
~0.6 > NMDG+ ~0.3, which is presumably based on the reported
voltages referring to the pipette relative to the bath electrode (i.e.
inverted from standard electrophysiological convention). The data
indicate that reconstituted 3a protein generates a non-selective
cationic channel potentially with a large pore (to accommodate
A
B
FIGURE 2 | 3a Protein topology and sequence alignment among corona viruses (A) 3a protein topology. (B) Multiple sequence alignment of 3a protein from corona
viruses. Secondary structures [alpha helices (coils) and beta strands (arrows)] observed in the EM structure by Kern et al. (41) are indicated. Transmembrane regions
(gray), novel mutations in CoV-2 (red), TRAF-binding motif (blue), epitopes for natural antibodies against 3A (orange), cysteines involved in dimer formation (magenta),
internalization signal (purple), ER trafficking motif (green) and caveolin binding motif (cyan) are shown. Triangles indicate mutations suggested to affect 3a ion channel
activity; dots indicate potentially critical residues inferred from the new EM structure.
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NMDG+) and high single channel conductance (375 pS at – 80
mV). Permeation of large ions would likely require significant
conformational changes from the resolved structure, given its
narrow minimum pore radius. Of note is that single channel
properties of 3a proteins were highly dependent on the permeating
ions in particular with substantial flickering with Ca2+ and much
smaller unitary conductances with NMDG+, Ca2+, and Na+ than
with K+ ions, which suggests that the protein may undergo
permeant ion-dependent conformational changes. Unexplained
is how cation selectivity might arise: the cytoplasmic sites through
which ion and water are proposed to enter the permeation
pathways all exhibit positive potential (Figure 3); the inner
cavity holds 5 basic residues per subunit while D142 is the only
acidic residue in that space (Figure 3).
Modulation of 3a Ion Channel Function
and Virus Pathogenicity
Overexpression of 3a in eukaryotic cells induces apoptosis,
manifested in nuclear condensation, caspase-8 and -9 activity,
increased cytosolic cytochrome C signaling in cultured cells and
the development of a “rough-eye” phenotype associated with
apoptosis in Drosophila (62). In the presence of the potassium
channel inhibitors 4-AP and Ba2+, or when the C133A/Y160A
mutations were included, apoptotic markers were significantly
reduced. However, channel inhibitors or mutations only resulted
in partial reversal of pathology, which was not quantitatively
matched to the complete loss of K+ currents (62), consistent with
3a-driven apoptosis being at most only partly dependent on
channel activity. Overexpression of 3a also causes necrotic host
cell death with concurrent secretions of pro-inflammatory
cytokines (12, 63), but the triple C127S/C130S/C133S
mutation, which abolishes ion channel function and reduces
tetramerization, did not affect pro-inflammatory IL-8 production
(12). In addition, both WT 3a and the C133A mutant provoked
similar NLR family pyrin domain containing 3 (NLRP3)
inflammasome activation (63). These results indicate that ion
channel activity of 3a protein per se may not be critical for
triggering necrotic cell death.
A
B C
FIGURE 3 | High-resolution 3a protein structure (A) Model of 3a dimer (left) and dimer-of-dimer (right) proteins embedded in lipid nanodiscs (PDB: 6XDC) (41).
(B) (above) Location of charged residues within the cavity. (below) Location of cysteine residues near the dimer-dimer interface. (C) Space-filling model colored to
illustrate the isoelectric potential of the dimeric protein (+3 blue and −3 red) computed by PDB2PQR (42) and APBS (43) webservers with default settings.
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Two molecules identified from traditional Chinese medicines
have been reported to inhibit 3a K+ conduction. Early studies
indicated that Emodin, an anthraquinone compound first
identified with an inhibitory effect on S protein interaction
with angiotensin converting enzyme 2 (ACE2) (72) both
inhibited 3a K+ conduction and half inhibited virus release at
~20 µM (69). Juglanin, a kaempferol glycoside, also completely
blocked 3a-mediated current at 10 µM (69), but its influence on
viral release was not tested. The recent study by Kern et al.
showed that Emodin did not affect purified 3a channel activity,
and no Emodin electron density was detected in their single
particle cryo EM trial of 3a proteins in the presence of the
compound (41). These results might imply that emodin effects
on 3a proteins observed in cells is indirect.
Potential Future Studies of 3a
Electrophysiology
Recombinant expression in eukaryotic cells provided evidence
that 3a generates K+-selective channels, whereas bilayer
recordings suggest that 3a generates relatively cation non-
selective channels. Ion selectivity is likely to be an intrinsic
property of any channel, and such a discrepancy between
cellular and bilayer studies is disconcerting. Moreover, ion
selectivity is the key determinant of the functional relevance of
any ion channel, and without clarity on this, any role for ion
channel activity of 3a in virus biology will remain unclear. While
the studies by Kern et al. strongly suggest that 3a proteins are
indeed non-selective cation channels, Ba2+ sensitivity of the
purified and reconstituted 3a proteins has not been examined.
This could be a critical test of whether Ba2+ sensitive currents
observed in 3a transfected eukaryotic cells are carried by 3a or by
other K channels whose expression might have been augmented
by 3a proteins. If the latter turns out to be the case, just how Ba2+
sensitive potassium currents are induced by 3a proteins would be
of particular importance.
4a Protein
HCoV-229E is generally considered a relatively benign human
coronavirus responsible for the common cold, although a recent
case report documenting an infection associated with ARDS
suggests a potentially more dangerous pathology (73). The
HCoV-229E genome includes Orf4a (4a) which encodes a
short (133 AA) accessory protein with some limited homology
(17% identity) with SARS-CoV 3a, and transmembrane domain
prediction programs have been used to suggest that 4a shares the
3 TMD architecture reported for 3a (74). When 4a was expressed
in HCoV-229E infected Huh-7 cells, tagged proteins were shown
to localize with a marker of the endoplasmic reticulum/Golgi
intermediate compartment (74), as previously reported
elsewhere for SARS-CoV 3a (51, 75) and HCoV-NH63 ORF3
(76). Intriguingly, 4a expression also rescued survival in a
potassium-transporter deficient yeast strain (74), good
evidence that 4a either mediates K+ transport directly, or
activates an endogenous transport mechanism. In contrast to
3a, expression of 4a in Xenopus oocytes resulted in small currents
that exhibited distinctive time-dependent activation at negative
voltages. Although the authors proposed these were cation
currents, they are reminiscent of endogenous Cl− conductances
that have previously been reported following expression of
multiple influenza virus proteins in oocytes (77). Anion
substitution experiments, which might have ruled out this
possibility, were not performed. Although cation substitution
experiments appeared to show some selectivity for Li+, Na+ and
Cs+ over K+ or Rb+, the magnitude of the conductances were too
small for reliable assessment of reversal potential. Permeation of
larger cations could be informative but, again, mutational
analyses to probe specific channel properties are necessary to
definitively test the ion channel function of 4a.
8a Protein
The hydrophobic 39 AA SARS-CoV 8a peptide came into being
following a remarkable genetic event, apparently occurring shortly
after zoonotic transmission to humans, in which a 29-nt deletion
split the ORF8 gene (which encodes the full-length 8ab+ protein
found in animals and early human isolates) into two distinct open
reading frames, resulting in 8a and 8b peptides (78). Antibodies
against 8a have been found in a small subset of SARS patients,
suggesting the protein is expressed in infected humans. 8a has
been implicated in viral replication and the induction of apoptosis,
and has been reported to localize within mitochondria or within
the endoplasmic reticulum (79, 80). However, a recent study using
mouse-adapted (MA15) recombinant SARS showed no major
effect of 8a deletion on virus titer in Vero E6 cells, virus growth
in vivo in BALB/c mice, or mouse survival (9). Chen et al. (81)
used in silico prediction of transmembrane topology and
molecular dynamics simulations to propose multiple potential
oligomultimers, including tetrameric-, pentameric-, and
hexameric channel-like complexes, with hydrated pores lined by
serine, threonine and cysteine residues (Figure 1). Subsequent
MD simulations of pentameric 8a complexes were used for
potential of mean force (PMF) calculations for Na+, K+, Cl−,
and Ca2+ ions along the predicted permeation pathway (82).
Similar peak PMF energy values around 2 kcal/mol were
observed for all ions tested, yet Cl− ions permeated more readily
under applied voltages — an effect attributed to a voltage-
dependent widening of the pore during 50 ns permeation
simulations which was not present in the brief PMF
calculations. Experimental characterization of 8a has been
limited to a single electrophysiological study of synthesized 8a
peptide reconstituted into artificial lipid bilayers (81).
Representative traces show noisy channel-like events and Ohmic
behavior with low (~9 pS) conductance in symmetrical 300 mM
KCl solutions. A ten-fold asymmetric elevation in ion
concentration in the trans-chamber of the bilayer set-up resulted
in an ~+30mV shift in the reversal potential, which implies a weak
cation-selectivity, in apparent conflict with the MD permeation
studies and with the minor differences in peak energy barrier for
cations and anions in PMF calculations (82). Unfortunately, the
study again raises questions regarding overall interpretations: for
example, it is not clear how the authors could reliably resolve the
mean conductance in asymmetric ionic conditions given the tiny
currents at the voltage cited (their Figure 2E).
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Additional electrophysiological studies are needed to establish
whether 8a indeed forms an ion channel, and there is currently no
evidence that modulation of putative ion channel activity of 8a
leads to anti-viral and/or pro-host effects. Predictions from in silico
modeling of voltage-dependent changes in the narrowest region of
the pore (from N-terminal side at 0 mV to the C-terminal side at
45 mV), an overall decrease in the minimal pore radius with
increasing voltage, and a specific increase in the observed Cl−
permeation at positive voltages may point toward voltage-
dependent changes in ion selectivity, conductance, or open
probability which could be tested by further electrophysiological
analysis. Furthermore, the relatively small minimum pore radius
proposed (81, 82) suggests that permeant ion substitution with
large ions (such as NMDG, quaternary ammonium ions,
gluconate) should lead to marked decrease in conductance or
channel block. For 8a, as for all other putative viroporins,
mutagenesis studies, guided by predicted structures and
involving alterations of pore electrostatics, alongside detailed ion
substitution experiments in multiple cell types (to mitigate the
confounding effects of endogenous channels) could provide clear-
cut evidence of bona fide ion channel behavior.
CONCLUDING REMARKS
In conclusion, despite a large number of reports, definitive
studies regarding SARS-CoV viroporin activity remain few,
and the strength of evidence for bona fide ion channel
behavior of any SARS-CoV protein has until now been limited.
It is not trivial to unequivocally demonstrate intrinsic ion
channel activity of a protein but the field would benefit from
detailed, parallel studies of channel behaviors in multiple
systems. Identification of mutations that specifically modify
channel properties (i.e. gating, selectivity) provides the gold
standard for such studies, but is currently absent from the
SARS-CoV field. The recent study of Kern et al. provides a
high-resolution structure of 3a and compelling evidence of
channel activity, although, at the time of writing, this study is
still only published in pre-print form. Even when ion channel
activity is convincingly demonstrated, determining functional
relevance is of course difficult. This may be especially true
for viruses, where a single viral protein may exhibit several
discrete activities that do not translate predictably to
pathogenic functions
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